Humanized anti-human α9-integrin antibody
    1.
    发明授权
    Humanized anti-human α9-integrin antibody 有权
    人源化抗人α9整联蛋白抗体

    公开(公告)号:US08603476B2

    公开(公告)日:2013-12-10

    申请号:US12812341

    申请日:2009-01-09

    IPC分类号: A61K39/395

    摘要: The present invention provides a humanized anti-human α9 integrin antibody having improved activity and/or property as compared to a donor mouse anti-human α9 integrin antibody, namely, a humanized anti-human α9 integrin antibody containing a heavy-chain variable region consisting of the amino acid sequence shown by SEQ ID NO:11 and a light-chain variable region consisting of the amino acid sequence shown by SEQ ID NO:17, a humanized anti-human α9 integrin antibody containing a heavy-chain variable region consisting of the amino acid sequence shown by SEQ ID NO:13 and a light-chain variable region consisting of the amino acid sequence shown by SEQ ID NO:17, a humanized anti-human α9 integrin antibody containing a heavy-chain variable region consisting of the amino acid sequence shown by SEQ ID NO:15 and a light-chain variable region consisting of the amino acid sequence shown by SEQ ID NO:9, and a means for the prophylaxis or treatment of various diseases involving human α9 integrin in the pathogenesis, which uses the antibody.

    摘要翻译: 本发明提供与供体小鼠抗人α9整联蛋白抗体相比具有改善的活性和/或性质的人源化抗人α9整联蛋白抗体,即包含重链可变区的人源化抗人α9整联蛋白抗体,其包含 的SEQ ID NO:11所示的氨基酸序列和由SEQ ID NO:17所示的氨基酸序列组成的轻链可变区,含有重链可变区的人源化抗人α9整联蛋白抗体包含由 由SEQ ID NO:13所示的氨基酸序列和由SEQ ID NO:17所示的氨基酸序列组成的轻链可变区,含有重链可变区的人源化抗人α9整联蛋白抗体 由SEQ ID NO:15所示的氨基酸序列和由SEQ ID NO:9所示的氨基酸序列组成的轻链可变区,以及预防或治疗涉及 人类α9整联蛋白在发病机制中使用抗体。

    HUMANIZED ANTI-HUMAN ALPHA 9-INTEGRIN ANTIBODY
    2.
    发明申请
    HUMANIZED ANTI-HUMAN ALPHA 9-INTEGRIN ANTIBODY 有权
    人类抗人ALPHA 9整合抗体

    公开(公告)号:US20110059077A1

    公开(公告)日:2011-03-10

    申请号:US12812341

    申请日:2009-01-09

    摘要: The present invention provides a humanized anti-human α9 integrin antibody having improved activity and/or property as compared to a donor mouse anti-human α9 integrin antibody, namely, a humanized anti-human α9 integrin antibody containing a heavy-chain variable region consisting of the amino acid sequence shown by SEQ ID NO:11 and a light-chain variable region consisting of the amino acid sequence shown by SEQ ID NO:17, a humanized anti-human α9 integrin antibody containing a heavy-chain variable region consisting of the amino acid sequence shown by SEQ ID NO:13 and a light-chain variable region consisting of the amino acid sequence shown by SEQ ID NO:17, a humanized anti-human α9 integrin antibody containing a heavy-chain variable region consisting of the amino acid sequence shown by SEQ ID NO:15 and a light-chain variable region consisting of the amino acid sequence shown by SEQ ID NO:9, and a means for the prophylaxis or treatment of various diseases involving human α9 integrin in the pathogenesis, which uses the antibody.

    摘要翻译: 本发明提供与供体小鼠抗人α9整联蛋白抗体相比具有改善的活性和/或性质的人源化抗人α9整联蛋白抗体,即包含重链可变区的人源化抗人α9整联蛋白抗体,其包含 的SEQ ID NO:11所示的氨基酸序列和由SEQ ID NO:17所示的氨基酸序列组成的轻链可变区,含有重链可变区的人源化抗人α9整联蛋白抗体由 由SEQ ID NO:13所示的氨基酸序列和由SEQ ID NO:17所示的氨基酸序列组成的轻链可变区,包含由SEQ ID NO:17所示的重链可变区组成的人源化抗人α9整联蛋白抗体 由SEQ ID NO:15所示的氨基酸序列和由SEQ ID NO:9所示的氨基酸序列组成的轻链可变区,以及用于预防或治疗涉及人α9整数的各种疾病的手段 rin在发病机制中,其使用抗体。

    HUMANIZED ANTI-HUMAN ALPHA 9-INTEGRIN ANTIBODY
    3.
    发明申请
    HUMANIZED ANTI-HUMAN ALPHA 9-INTEGRIN ANTIBODY 审中-公开
    人类抗人ALPHA 9整合抗体

    公开(公告)号:US20110014193A1

    公开(公告)日:2011-01-20

    申请号:US12812368

    申请日:2009-07-09

    摘要: The present invention provides a humanized anti-human α9 integrin antibody having improved activity and/or property as compared to donor mouse anti-human α9 integrin antibody, namely, a humanized anti-human α9 integrin antibody comprising a heavy-chain variable region consisting of the amino acid sequence shown by SEQ ID NO: 1 or the amino acid sequence shown by SEQ ID NO: 1 wherein one or several amino acids are substituted, deleted, inserted and/or added and a light-chain variable region consisting of the amino acid sequence shown by SEQ ID NO: 61 or the amino acid sequence shown by SEQ ID NO: 61 wherein one or several amino acids are substituted, deleted, inserted and/or added, as well as a means for preventing or treating various diseases involving human α9 integrin in their pathogenesis, which uses the antibody.

    摘要翻译: 本发明提供了与供体小鼠抗人α9整联蛋白抗体相比具有改善的活性和/或性质的人源化抗人α9整联蛋白抗体,即人源化抗人α9整联蛋白抗体,其包含由以下组成的重链可变区: SEQ ID NO:1所示的氨基酸序列或SEQ ID NO:1所示的氨基酸序列,其中一个或几个氨基酸被取代,缺失,插入和/或添加,以及由氨基酸组成的轻链可变区 SEQ ID NO:61所示的酸序列或SEQ ID NO:61所示的氨基酸序列,其中一个或几个氨基酸被取代,缺失,插入和/或添加,以及用于预防或治疗涉及 人α9整合素在其发病机制中,其使用抗体。

    Lens driving apparatus, optical apparatus and control method for lens driving apparatus
    6.
    发明授权
    Lens driving apparatus, optical apparatus and control method for lens driving apparatus 有权
    透镜驱动装置,光学装置及透镜驱动装置的控制方法

    公开(公告)号:US08780455B2

    公开(公告)日:2014-07-15

    申请号:US12643877

    申请日:2009-12-21

    申请人: Daisuke Ishikawa

    发明人: Daisuke Ishikawa

    IPC分类号: G02B15/14

    摘要: The lens driving apparatus moves a magnification-varying lens and moves a focus lens to compensate for image plane variation caused by movement of the magnification-varying lens. The apparatus includes a zoom operating member, a stepping motor, a zoom controller controlling drive of the stepping motor, a focus actuator moving the focus lens, a focus controller controlling drive of the focus actuator, a memory storing cam data to compensate for the image plane variation, and a zoom position detector. During a magnification variation operation, the zoom controller performs open-loop control of the drive of the stepping motor based on an operation amount of the zoom operating member, and the focus controller controls the drive of the focus actuator based on the actual position of the magnification-varying lens detected by the zoom position detector, and the cam data.

    摘要翻译: 透镜驱动装置移动变倍透镜并移动聚焦透镜以补偿由放大率变化透镜的移动引起的图像平面变化。 该装置包括变焦操作构件,步进电机,控制步进电机驱动的变焦控制器,移动聚焦透镜的聚焦致动器,控制聚焦致动器驱动的聚焦控制器,存储凸轮数据以补偿图像的存储器 平面变化和变焦位置检测器。 在放大变化操作期间,变焦控制器基于变焦操作构件的操作量执行对步进电动机的驱动的开环控制,并且焦点控制器基于实际位置来控制聚焦致动器的驱动 由变焦位置检测器检测的变倍透镜和摄像机数据。